SANDERCOCK BRETT (Chief Financial Officer) sold 1.1% of their position (1K shares) of RESMED INC on the open market
Open‑market sale worth $244.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/2/2025ACC: 0000943819-25-000184
Officer· Chief Financial Officer
Since Mar 2026
-1K
Net shares
Net seller
$244.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1K disposed
Non-Derivative Transactions1
ResMed Common Stock
Direct
Shares
−1K
Price / share
$244.16
Trade value
$244.16K
% of position
1.1%
12/1/2025
88.50K→87.50K
Total
Net shares
−1K
Net value
-$244.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock Direct | 12/1/2025 | S · Sale | −1K | $244.16 | $244.16K | 1.1% | 88.50K | 87.50K |
| Total | −1K | -$244.16K | ||||||
Derivative Transactions0
No derivative transactions reported